Published on
May 10, 2025
FDA approves first cell-based gene therapy for rare, devastating skin disorder â but it comes with a huge price tag
FDA approves first cell-based gene therapy for rare, devastating skin disorder – but it comes with a huge price tag The FDA approved Zevaskyn, the first cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), a rare and painful …
Source:
Natural News
-
Right-wing
:max_bytes(150000):strip_icc()/baked-beans-recall-2025-FT-BLOG0525-e4201f9b60b444168a532865c09c736d.jpg)
